HPLC测定长春西汀注射液中杂质的含量
摘要
关键词
全文:
PDF参考
[1]贺媛.早期康复护理应用于脑血管疾病患者的作用探讨[J].按摩与康复医学,2019,10(10):58-59.[2]YuDandan,LiaoXing,RobinsonNicola,etal.12kindsofChinesemedicineinjectionsforacutecerebralinfarction:Protocolforasystematicreviewandnetworkmeta-analysis[J].EuropeanJournalofIntegrativeMedicine,2019,27:75-80.[3]KazuhiroOhwaki,AkiraTamura,TomohiroInoue,etal.RiskFactorsforCerebralArteriosclerosisDetectedbyMagneticResonanceAngiographyinBrainCheck-ups[J].NingenDockInternational,2016,4(1):28-31.[4]刘怀志.脑血管疾病的药物治疗药物合理应用管理[J].中国卫生产业,2017,14(09):114-115.[5]PandaPrateekKumar,RamachandranAparna,PandaPragnya,SharawatIndarKumar.SafetyandEfficacyofVinpocetineasaNeuroprotectiveAgentinAcuteIschemicStroke:ASystematicReviewandMeta-Analysis[J].Neurocriticalcare,2022.[6]Yi-shuaiZhang,Jian-dongLi,ChenYan.Anupdateonvinpocetine:Newdiscoveriesandclinicalimplications[J].EuropeanJournalofPharmacology,2018,819.[7]ZhangYishuai,LiJiandong,YanChen.Anupdateonvinpocetine:Newdiscoveriesandclinicalimplications[J].Europeanjournalofpharmacology,2018,819:30-34.[8]沈永辉.长春西汀药理作用与临床应用观察[J].医学信息,2015,28(2):322.[9]蒋金富.长春西汀临床应用研究进展[J].甘肃科技,2010,26(01):173-174.[10]国家药典委员会.国家药品标准新药转正标准(第78册)[M].北京:中国医药科技出版社,2011:167-168.
DOI: http://dx.doi.org/10.12361/2661-3603-05-03-115254
Refbacks
- 当前没有refback。